FDA post-market role criticized
185982
The editors of the Journal of the American Medical Association (JAMA) are calling for an end to the US Food and Drug Administration&#39;s (FDA) role in post-market monitoring of the safety of drugs it approves.
11646
The U.S. Food and Drug   Administration needs more staff, funding and power over the   drug industry to better police the safety of medicines after   they reach the market, an Institute of Medicine panel said on   Friday.
118476
Critics say the F.D.A.'s efforts to monitor the ill effects of drugs that are on the market are a shadow of what they should be.
596898
Two US regulators defended the Food and Drug Administration's handling of the withdrawn painkiller Vioxx, disputing the contention of heart researcher Dr. Eric Topol that the agency could have forced Merck &amp; Co. to do more safety testing.
368795
The U.S. Food and Drug Administration on Friday asked an outside group to review the way the agency monitors safety risks of medicines after they hit the market, such as Merck & Co. Inc.'s withdrawn painkiller Vioxx.
767854
Nearly 20 percent of U.S. Food and Drug Administration scientists surveyed in late 2002 said they were pressured to approve or recommend approval of a medicine despite their reservations about the drug's risks or effectiveness, according to documents made public on Thursday.
124030
Almost one-fifth of the Food and Drug Administration scientists surveyed two years ago as part of an official review said they had been pressured to recommend approval of a new drug despite
552741
U.S. lawmakers criticized the Food and Drug Administration's monitoring of the risks of a Sanofi-Aventis antibiotic and some other prescription drugs on Tuesday.
2756
NEW YORK - The pharmaceutical industry has endured a disastrous 2004, and the aftermath will linger into the new year. Regulators at the Food and Drug Administration were expected to take a more cautious approach
518488
The US regulator to beef up monitoring of drug safety after criticism over a painkiller linked to heart disease.
683077
U.S. lawmakers criticized the Food  and Drug Administration's monitoring of the risks of the  antibiotic Ketek (Sanofi-Aventis) and some other prescription  drugs on Tuesday.
242819
The Food and Drug Administration remains on the defensive. The agency got grilled on Capitol Hill for the second day in a row about the health risks of several popular prescription drugs.
452827
The federal Food and Drug Administration&#39;s ability to protect the American public is in question in the wake of the problems with this year&#39;s flu vaccine shortage and claims that it is allowing unsafe drugs to remain on the market.
672654
The prescription drug industry has grown enormously in the past few years, to the tune of an estimated $200 billion every year. Consumers and medical professionals have sharpened their criticism of the industry
565358
In the face of growing public distrust, the US Food and Drug Administration remains unpersuasive in claiming that its review of prescription drugs is sufficient or places the consumer first.
236669
With yet more already-marketed medicines raising the ire of consumer advocates and regulators alike, momentum is building for reform of the governmentâs drug approval and monitoring procedures.
130395
Critics charge conflict of interest in a system where pharmaceutical giants fund the regulatory process. By Alexandra Marks | Staff writer of The Christian Science Monitor.